title: Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting.
abstract: OBJECTIVE
  We examined all-cause mortality within a primary care setting in patients with white coat hypertension or sustained hypertension in whom blood pressure (BP) monitoring was indicated.
  
  
  METHODS
  This prospective multicenter study of ambulatory BP monitoring included 48 family practices in the county of Oxfordshire, United Kingdom. Mortality was compared for patients having white coat hypertension (mean of 3 clinic BP readings >140/90 mm Hg and daytime ambulatory readings< or =135/85 mm Hg) and patients having sustained hypertension (mean of 3 clinic readings >140/90 mm Hg and daytime ambulatory readings >135/85 mm Hg).
  
  
  RESULTS
  A routine primary care cohort consisting of 5,182 patients chosen to undergo ambulatory BP monitoring by their family physician was followed up for a median of 7.3 years (interquartile range, 5.8-8.9). There were 335 deaths (6.5%), corresponding to a mortality rate of 8.9 deaths (95% confidence interval [CI], 8.0-9.9) per 1,000 years of follow-up. Patients with white coat hypertension (n = 1,117) were more likely to be female and were on average younger than patients with sustained hypertension (n = 4,065). The unadjusted rate of all-cause mortality in patients with white coat hypertension was lower, at 4.4 deaths per 1,000 years of follow-up (95% CI, 3.1-6.0) than that in patients with sustained hypertension, at 10.2 deaths per 1,000 years of follow-up (95% CI, 9.1-11.4). This reduction in all-cause mortality was still clinically significant after adjustment for age, sex, smoking, use of antihypertensive medication, and practice-clustering effects (hazard ratio = 0.64; 95% CI, 0.42-0.97; P=.04).
  
  
  CONCLUSIONS
  White coat hypertension (elevation of clinic BP only) confers significantly less risk of death than sustained hypertension (elevation of both clinic and ambulatory BPs). Trials are now needed to evaluate the risk reduction achievable in patients who have white coat hypertension and are receiving BP-lowering therapy.
authors.affiliation: Department of Family Medicine, McGill University, Montreal, Quebec, Canada. martin.dawes@mcgill.ca
authors.forename: Martin G
authors.initials: MG
authors.lastname: Dawes
authors.forename: Gillian
authors.initials: G
authors.lastname: Bartlett
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Coats
authors.forename: Edmund
authors.initials: E
authors.lastname: Juszczak
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D018660:Blood Pressure Monitoring, Ambulatory; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D011320:Primary Health Care / Q000706:statistics & numerical data*; D011446:Prospective Studies; D018570:Risk Assessment; D017678:Sex Distribution; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents
references.citation: Arch Intern Med. 1993 Dec 27;153(24):2741-8
references.pmid: 8257249
references.citation: Eur Heart J. 2000 Oct;21(20):1714-8
references.pmid: 11032699
references.citation: JAMA. 1983 May 27;249(20):2792-8
references.pmid: 6842787
references.citation: S Afr Med J. 2000 Sep;90(9):898-904
references.pmid: 11081143
references.citation: Circulation. 2005 Apr 12;111(14):1777-83
references.pmid: 15809377
references.citation: Int J Epidemiol. 1986 Mar;15(1):122-5
references.pmid: 3957533
references.citation: J Hum Hypertens. 2005 Oct;19(10):801-7
references.pmid: 15959536
references.citation: Am J Hypertens. 1992 Feb;5(2):64-70
references.pmid: 1550667
references.citation: Lancet. 1990 Apr 7;335(8693):827-38
references.pmid: 1969567
references.citation: Hypertension. 1994 Dec;24(6):793-801
references.pmid: 7995639
references.citation: J Am Coll Cardiol. 2002 Mar 6;39(5):878-85
references.pmid: 11869856
references.citation: Am J Hypertens. 1999 Mar;12(3):251-9
references.pmid: 10192226
references.citation: Am Heart J. 1988 Oct;116(4):1118-23
references.pmid: 3177187
references.citation: J Am Board Fam Pract. 1998 Jul-Aug;11(4):252-8
references.pmid: 9719346
references.citation: J Hum Hypertens. 2003 Dec;17(12):811-7
references.pmid: 14704724
references.citation: J Cardiovasc Pharmacol. 1994;23 Suppl 5:S5-11
references.pmid: 7609507
references.citation: Br Med J (Clin Res Ed). 1985 Jul 13;291(6488):97-104
references.pmid: 2861880
references.citation: Br J Gen Pract. 2003 Jan;53(486):61-2
references.pmid: 12564285
references.citation: Arch Fam Med. 1995 Aug;4(8):691-6
references.pmid: 7620599
references.citation: JAMA. 1988 Jan 8;259(2):225-8
references.pmid: 3336140
references.citation: BMJ. 1996 Dec 14;313(7071):1535-41
references.pmid: 8978234
references.citation: Cardiovasc Drugs Ther. 1989 Jun;3 Suppl 1:303-11
references.pmid: 2487802
references.citation: Can J Cardiol. 2006 May 15;22(7):573-81
references.pmid: 16755312
references.citation: Hypertension. 1985 Mar-Apr;7(2):171-7
references.pmid: 3156813
references.citation: J Hypertens Suppl. 1989 May;7(3):S29-32
references.pmid: 2668462
references.citation: Am J Hypertens. 1993 Jun;6(6 Pt 2):207S-210S
references.pmid: 8347320
references.citation: Blood Press Monit. 2000 Aug;5(4):223-6
references.pmid: 11035864
references.citation: Am J Hypertens. 2005 Oct;18(10):1369-74
references.pmid: 16202864
references.citation: Lancet. 2002 Dec 14;360(9349):1903-13
references.pmid: 12493255
references.citation: Blood Press Monit. 2006 Jun;11(3):111-8
references.pmid: 16702819
references.citation: J Am Coll Cardiol. 2005 Aug 2;46(3):508-15
references.pmid: 16053966
references.citation: Clin Exp Hypertens. 1993 Mar;15(2):271-87
references.pmid: 8467317
references.citation: J Am Board Fam Pract. 2001 May-Jun;14(3):166-71
references.pmid: 11355047
references.citation: J Hypertens. 1997 Apr;15(4):357-64
references.pmid: 9211170
references.citation: Med Sci Monit. 2005 Sep;11(9):CR403-9
references.pmid: 16127357
references.citation: J R Soc Med. 1998 Jun;91(6):301-4
references.pmid: 9771513
references.citation: J Hum Hypertens. 2001 Oct;15(10):681-4
references.pmid: 11607797
references.citation: Chronobiol Int. 2001 Jan;18(1):85-98
references.pmid: 11247116
references.citation: J Hypertens. 2007 Aug;25(8):1554-64
references.pmid: 17620947
references.citation: J Hypertens. 1999 Feb;17(2):151-83
references.pmid: 10067786
references.citation: Am J Hypertens. 1991 Nov;4(11):890-6
references.pmid: 1789952
references.citation: Br Med J (Clin Res Ed). 1982 Oct 2;285(6346):919-23
references.pmid: 6811068
references.citation: Obstet Gynecol. 1991 Jan;77(1):152-5
references.pmid: 1984216